- Home
- FCN vs BRKR Comparison
FCN vs BRKR Comparison
Compare FCN & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCN
- BRKR
- Stock Information
- Founded
- FCN 1982
- BRKR 1960
- Country
- FCN United States
- BRKR United States
- Employees
- FCN N/A
- BRKR N/A
- Industry
- FCN Professional Services
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- FCN Consumer Discretionary
- BRKR Industrials
- Exchange
- FCN Nasdaq
- BRKR Nasdaq
- Market Cap
- FCN 5.9B
- BRKR 5.8B
- IPO Year
- FCN 1996
- BRKR 2000
- Fundamental
- Price
- FCN $162.84
- BRKR $39.07
- Analyst Decision
- FCN Hold
- BRKR Buy
- Analyst Count
- FCN 2
- BRKR 12
- Target Price
- FCN $175.50
- BRKR $63.40
- AVG Volume (30 Days)
- FCN 467.7K
- BRKR 2.7M
- Earning Date
- FCN 04-24-2025
- BRKR 05-07-2025
- Dividend Yield
- FCN N/A
- BRKR 0.51%
- EPS Growth
- FCN N/A
- BRKR N/A
- EPS
- FCN 7.32
- BRKR 0.76
- Revenue
- FCN $3,668,381,000.00
- BRKR $3,366,400,000.00
- Revenue This Year
- FCN $1.36
- BRKR $5.57
- Revenue Next Year
- FCN $6.38
- BRKR $5.63
- P/E Ratio
- FCN $22.22
- BRKR $51.34
- Revenue Growth
- FCN 1.59
- BRKR 13.56
- 52 Week Low
- FCN $151.75
- BRKR $34.10
- 52 Week High
- FCN $243.60
- BRKR $84.90
- Technical
- Relative Strength Index (RSI)
- FCN 47.37
- BRKR 45.87
- Support Level
- FCN $163.01
- BRKR $37.00
- Resistance Level
- FCN $172.29
- BRKR $39.85
- Average True Range (ATR)
- FCN 4.99
- BRKR 2.52
- MACD
- FCN 0.64
- BRKR 0.43
- Stochastic Oscillator
- FCN 53.99
- BRKR 64.20
About FCN FTI Consulting Inc.
FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.